Podcast Urges Balanced Oversight for AI in Medicine
This episode argues that AI should not be halted or drastically slowed, but should be guided by governance and safeguards. It notes concerns that AI capabilities may outpace risk controls while also highlighting potential gains in drug discovery, cost reduction, and patient outreach. The host calls for a risk-based regulatory approach that preserves innovation.
Expanded Detail
EXPANDED:
In episode 146, released September
Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “146. AI in Healthcare: Innovate, But With Guardrails.” Browse more stories.